C07C 53/134
Monocyclic
Official title: monocyclic
C07C53/134 (Monocyclic) appears on 82 US grants and 41 published applications in this corpus.
Search patents in C07C- Granted patents
- 82
- Published applications
- 41
- Assignees
- 44
- Inventors
- 133
- Latest grant
- 15 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 4 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 10 | 0 |
| 1997 | 16 | 0 |
| 1998 | 3 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 2 | 2 |
| 2004 | 1 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 2 |
| 2011 | 0 | 1 |
| 2012 | 1 | 1 |
| 2013 | 2 | 0 |
| 2014 | 3 | 2 |
| 2015 | 4 | 4 |
| 2016 | 2 | 3 |
| 2017 | 0 | 2 |
| 2018 | 1 | 2 |
| 2019 | 2 | 2 |
| 2020 | 5 | 5 |
| 2021 | 1 | 1 |
| 2022 | 3 | 1 |
| 2023 | 1 | 1 |
| 2024 | 0 | 3 |
| 2025 | 1 | 4 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Highly accurate de novo polynucleotide synthesis15 Jul 2025US 12,357,959 B2Twist Bioscience Corporation
- PKC-activating compounds for the treatment of neurodegenerative diseases21 Nov 2023US 11,820,745 B2Synaptogenix, Inc.
- Substituted aromatic compounds and related method for the treatment of fibrosis13 Dec 2022US 11,524,930 B2Liminal Biosciences Limited
- Synthesis of terphenyl compounds2 Aug 2022US 11,401,235 B2Vectus Biosystems Limited
- PKC-activating compounds for the treatment of neurodegenerative diseases19 Jul 2022US 11,390,596 B2Synaptogenix, Inc.
- Cyclopropane Fatty Acid Modulators Of Peroxisome Proliferator-Activated Receptors29 Jan 2026US 2026/0027078 A1The Regents of the University of California
- Catalytic carboxycarbonylation of alkenes to form anhydrides4 Dec 2025US 2025/0368598 A1Eastman Chemical Company
- Highly accurate de novo polynucleotide synthesis20 Nov 2025US 2025/0352972 A1Twist Bioscience Corporation
- Method for producing 3-phenylpropionic acid analogue compounds3 Apr 2025US 2025/0109416 A1Maruzen Pharmaceuticals Co., Ltd.
- Anti-inflammatory Compounds, Pharmaceutical Compositions, and Treatment Methods20 Feb 2025US 2025/0059177 A1Miralogx LLC
Most cited
By later US patents
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Retroviral protease inhibiting compounds109US 5,354,866 AAbbott Laboratories · 1994
- Retroviral protease inhibiting compounds94US 5,541,206 AAbbott Laboratories · 1996
- Disubstituted ethanes61US 4,439,015 AHoffmann-La Roche Inc. · 1984
- Liquid crystal compounds50US 4,261,651 AThe Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and Northern Ireland · 1981